Apollo Hospitals Enterprise Ltd Share Price Today

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 200% at ₹10/Share	14-Aug-2026	14-Aug-2026
DividendsInterim Dividend of 200% at ₹10/Share	16-Feb-2026	16-Feb-2026
DividendsFinal Dividend of 200% at ₹10/Share	19-Aug-2025	19-Aug-2025
DividendsInterim Dividend of 180% at ₹9/Share	14-Feb-2025	15-Feb-2025

Mutual Fund Holder	Aug 26 Shares held	Sep 26 Shares held
SBI Nifty 50 ETF	19.96 Lac	19.96 Lac no change
HDFC Flexi Cap Fund - Growth	8.63 Lac	10.54 Lac (22.1%)
Axis Large Cap Fund - Regular Plan - Growth	10.41 Lac	10.41 Lac no change
ICICI Prudential Balanced Advantage Fund - Growth	6.17 Lac	6.97 Lac (12.96%)
UTI Nifty 50 ETF	6.84 Lac	6.85 Lac (0.02%)

SHUBINVESTS I SEBI RA

4 Nov • 9:58 PM · SEBI-Registered Analyst

HOW INDIA'S HEALTHCARE INDUSTRY IS ATTRACTING THE WORLD!

Imagine an Indian hospital treating patients not just from India but also from Cambodia, Vietnam, Mauritius, the Middle East, Africa and Europe. That's the growing opportunity in India's healthcare industry.

APOLLOHOSP

Ltd is expanding its healthcare business while attracting more international patients. Revenue from international patients increased by 37%. Healthcare services are attracting overseas patients through quality treatment and affordable costs. Its pharmacy network added 222 stores, taking the total to 7,662. Healthcare and lifestyle business revenue increased 20% to ₹429 crore. Tamil Nadu revenue grew 19.1% to ₹1,240 crore. The company plans to add approximately 5,800 hospital beds over the next five years. It is also investing in technology, cloud infrastructure and AI adoption to improve healthcare operations. India is becoming an attractive destination for affordable medical treatment. Growing international patient demand, hospital expansion and digital healthcare services could create long-term business opportunities. However, investors should also watch expansion costs, profitability, execution and valuation. Healthcare demand supports growth, but investors should track execution, occupancy, margins, capital spending, and valuation before drawing conclusions about performance.

Apurva Harsh Vira

4 Nov • 6:43 PM · SEBI-Registered Analyst

Apollo Hospitals Q2 Revenue Grows 23%, Profit Surges

APOLLOHOSP

reported a strong Q2 FY27 performance, reflecting continued demand for healthcare services and complex medical procedures. According to CNBC-TV18, the company’s revenue increased 23% year-on-year, while profit jumped more than 33%, with the headline reporting profit of around ₹660 crore. Reuters reported consolidated net profit of ₹630 crore for the quarter ended September 30, 2026, compared with ₹477 crore in the corresponding period last year, marking approximately 32% growth. The profit performance was broadly in line with analyst expectations, supported by strong demand in the core hospital business. The company’s growth reflects the broader opportunity in India’s healthcare sector, where increasing demand for specialised treatments, rising healthcare awareness and capacity expansion are important long-term drivers. Apollo’s hospital network and focus on complex care provide avenues for operational growth. However, investors should evaluate the performance across its key business segments, including healthcare services, diagnostics, retail pharmacy and digital health. Margin sustainability, occupancy levels, average revenue per patient, new hospital ramp-up and capital expenditure will remain important factors to monitor. Learning Takeaway: Healthcare companies should be assessed not only on revenue and profit growth, but also on patient volumes, case mix, occupancy, operating margins and the efficiency of new hospital capacity. These factors help determine whether earnings growth can remain sustainable over time. Disclosure: This post is for educational purposes only and does not constitute investment advice. Any holdings or conflicts of interest should be disclosed separately.

Umang Bhutada

4 Nov • 9:49 AM · SEBI-Registered Analyst

APOLLO HOSPITALS Q2 RESULTS TODAY WHAT TO EXPECT ?

APOLLOHOSP

Can healthcare demand support another strong quarter? Apollo Hospitals is scheduled to announce its Q2 FY27 results today, November 4. What investors should compare: In Q1 FY27, the company reported: Revenue: ₹7,043.5 crore. Operating profit: ₹1,092.1 crore. Net profit: ₹610.4 crore. Revenue grew around 20.6% YoY and net profit increased around 38.4% YoY in Q1. These are Q1 figures, not Q2 results or Q2 estimates. Why this matters: Apollo operates across hospitals, pharmacies and digital healthcare services. Investors will be looking for growth across its hospital network and improvements in operating profitability. What to monitor next: Hospital revenue growth Occupancy and average revenue per occupied bed EBITDA margins Pharmacy and digital healthcare performance Expansion plans and capital expenditure My analytical view: The key question is whether Apollo can sustain its strong Q1 growth while maintaining margins. Revenue growth without corresponding operating-profit improvement would need closer examination. Disclosure: State your actual holding or interest, if any, before publishing. SEBI RA Disclaimer: Umang Rajesh Bhutada is a SEBI-registered Research Analyst (INH000023001). This content is for educational and informational purposes only and is not investment advice. Securities investments are subject to market risks. Please consult a qualified financial professional before making investment decisions.

Hruthik N

28 Oct • 10:18 PM · SEBI-Registered Analyst

Markets End Lower as IT and Oil Stocks Drag

The Indian stock market ended in the red today, October 28, 2026, with the Nifty 50 falling 50.90 points (-0.22%) to 22,698.85, while the Sensex declined 352.64 points (-0.48%) to 73,246.03. Top Gainer - Nifty 50:

APOLLOHOSP

gained 4.43%, closing at ₹8,137. Top Loser - Nifty 50: Infosys fell 3.43%, closing at ₹1,123.15. What drove the market? • Heavy selling in IT stocks and oil-and-gas companies weighed on the benchmark indices. • Crude oil prices surged above $116 per barrel, raising concerns about inflation and market sentiment. • Investors remained cautious ahead of the US Federal Reserve’s policy decision. • Buying in auto, consumer durables and select banking stocks helped the market recover from intraday lows.

Shivansu Jaiswal

28 Oct • 8:25 PM · SEBI-Registered Analyst

Apollo Hospitals topped the Nifty 50 gainers

APOLLOHOSP

Enterprise Ltd emerged as the top gainer in the Nifty 50 on October 28, 2026, climbing 4.43% to close at ₹8,137. The stock outperformed the broader market, with the Nifty 50 declining 0.22% and the Sensex falling 0.48%. The strong upward movement indicates significant buying interest in the healthcare stock. Market participants will closely monitor the company's upcoming quarterly results, scheduled for November 4, 2026, for updates on revenue growth, profitability, and future business outlook. However, the specific reason behind today's rally remains unconfirmed. Investors will now focus on Apollo Hospitals' September-quarter financial results, scheduled for November 4, 2026, to assess its revenue growth, profitability, and business outlook. While the stock's strong performance attracted market attention, the exact trigger behind today's rally remains unconfirmed.

Vimal K

28 Oct • 5:44 PM · SEBI-Registered Analyst

Nifty Outlook for 29-Oct-2026 looks Bullish

The Nifty 50 closed at 22,698.85 (down 50.90 points or -0.22%) on Tuesday, October 28, 2026, pinning tightly near the 22,750 strike on monthly expiry day after swinging between an intraday low of 22,497.70 and a high of 22,778.05. The Daily MACD Histogram is above zero and the Hourly MACD Histogram is also above zero indicating a bullish trend. The Daily RSI 14 at 44.90 indicates a neutral to bearish trend and the Hourly RSI 14 above the midline 50 levels at 51.60 indicate a bullish trend. Thus, the overall trend of Nifty looks bullish, and the buyers are in control over the markets. Buy on dips would be the best strategy to deploy for today’s market considering the overall trend of Nifty. We may expect a change in trend only if the price sustains below the support level. Can Initiate selling only if prices continue to sustain below the support level. I have provided Nifty Spot resistance and support levels which would help you learn in taking informed trading decisions using these levels and understand how support and resistance levels work in financial markets. Nifty Spot Resistance 1 - 22850 Resistance 2 - 22895 Support 1 - 22570 Support 2 - 22530 Happy Learning, Happy Trading and have a wonderful day Top Gainers : APOLLOHOSP, LT, TRENT. Top Losers : INFY, RELIANCE, ONGC.

APOLLOHOSP

Apollo Hospitals Enterprise Ltd. Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About Apollo Hospitals Enterprise Ltd. 👋

Expert Opinions

Frequently Asked Questions

What is the share price of Apollo Hospitals Enterprise Ltd.?

What is the market cap of Apollo Hospitals Enterprise Ltd.?

Should I buy Apollo Hospitals Enterprise Ltd. stock now?

What is the 52 week high and low of Apollo Hospitals Enterprise Ltd.?

Is the Apollo Hospitals Enterprise Ltd. stock good to buy?

Is Apollo Hospitals Enterprise Ltd. a good buy for the long term?

Is Apollo Hospitals Enterprise Ltd. overvalued or undervalued?

What is the PE and PB ratio of Apollo Hospitals Enterprise Ltd.?